# Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

> **NCT00165204** · PHASE2 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 50 (—)

## Conditions studied

- Menopause
- Postmenopausal Bone Loss
- Breast Cancer

## Interventions

- **DRUG:** Tibolone

## Key facts

- **NCT ID:** NCT00165204
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 50 (—)
- **Last updated:** 2007-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165204, "Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00165204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*